7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Meet Veristat in Barcelona at the World Vaccine Congress 2023 , 16-19 October 2023
With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
If your goal is to mitigate emerging threats and advance human health, you need thoughtful planning and conduct for successful clinical development. Veristat’s scientific-minded, infectious disease experts are devoted to helping you navigate this critical and challenging landscape. Our teams have conducted over 350 projects for Infectious Disease treatments and vaccines, including more than 70 COVID-19 projects.
Whether you are aiming to prevent or combat a viral, bacterial, fungal, or parasitic infection, Veristat can help make the difference in your study’s success. Our teams have deep experience executing vaccine trials, and are adept with rapid response to global pandemics that arise, such as the recent COVID-19 response.
Don´t miss Veristat’s Medical Affairs specialists who will be presenting results from clinical studies for HIPRA’s BIMERVAX® SARS-CoV-2 vaccine.
Rachel Abu Taleb, MD, Medical Affairs Specialist, and Hugo Bernard, PhD, Mcs, Medical Affairs Associate, will present the poster on:
Overall superiority of PHH-1V (BIMERVAX®) protein Vaccine over BNT162b2 (Cominarty) mRNA Vaccine for Fully Vaccinated Individuals against a comprehensive set of SARS-CoV-2 Variants.
The posters will be displayed in the Congress Exhibition Hall with formal poster presentations scheduled at the following dates and times:
13:00 on Oct 17
13:00 on Oct 18
16:00 on Oct 19
If you would like to meet with us at the World Vaccine Congress, please contact us to arrange a meeting through the form.
We are…Bold. Scientific. Versatile. Veristat.
Website: World Vaccine Congress 2023

Meet with our Veristat colleagues at the World Vaccine Congress 2023:
7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...